NIH Public Access

Department of Biological Engineering, Massachusetts Institute of Technology, Building E19-551, 50 Ames Street, Cambridge, MA, 02139, USA.
Cancer Immunology and Immunotherapy (Impact Factor: 3.94). 05/2008; 57(12):1879-90. DOI: 10.1007/s00262-008-0518-1
Source: PubMed


Theoretical analyses suggest that the cellular internalization and catabolism of bound antibodies contribute significantly to poor penetration into tumors. Here we quantitatively assess the internalization of antibodies and antibody fragments against the commonly targeted antigen carcinoembryonic antigen (CEA). Although CEA is often referred to as a non-internalizing or shed antigen, anti-CEA antibodies and antibody fragments are shown to be slowly endocytosed by LS174T cells with a half-time of 10-16 h, a time scale consistent with the metabolic turnover rate of CEA in the absence of antibody. Anti-CEA single chain variable fragments (scFvs) with significant differences in affinity, stability against protease digestion, and valency exhibit similar uptake rates of bound antibody. In contrast, one anti-CEA IgG exhibits unique binding and trafficking properties with twice as many molecules bound per cell at saturation and significantly faster cellular internalization after binding. The internalization rates measured herein can be used in simple computational models to predict the microdistribution of these antibodies in tumor spheroids.

Download full-text


Available from: Greg M Thurber, Mar 27, 2014
35 Reads
  • Source
    • "We chose a carcinoembryonic antigen (CEA) specific single-chain Fv fragment (scFv) shMFE20, in which the inter domain linker (Gly4Ser)3 had been changed to (Gly4Ser)4 to increase the monomer to dimer ratio in the production process (Supplementary Fig. S1). A disulfide bond had been engineered to further stabilize the monomeric form of the construct21 by performing two amino acid substitutions: Gly to Cys and Ala to Cys at Kabat positions H44 and L100 respectively, resulting in a unique cystine-stabilized single-chain Fv fragment (sscFv). The location of the artificial cystine corresponds to that identified as a general site within the scFv framework to stabilize Fvs by disulfide bonds2223. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A major obstacle to the efficient production of antibody conjugates for therapy and diagnosis is the non-ideal performance of commonly used chemical methods for the attachment of effector-molecules to the antibody of interest. Here we demonstrate that this limitation can be simply addressed using 3,4-substituted maleimides to bridge and thus functionalize disulfide bonds to generate homogeneous antibody conjugates. This one-step conjugation reaction is fast, site-specific, quantitative and generates products with full binding activity, good plasma stability and the desired functional properties. Furthermore, the rigid nature of this modification by disulfide bridging enables the successful detection of antigen with a spin labeled antibody fragment by continuous-wave electron paramagnetic resonance (cw-EPR), which we report here for the first time. Antigen detection is concentration dependent, observable in human blood and allows the discrimination of fragments with different binding affinity. We envisage broad potential for antibody based in-solution diagnostic methods by EPR or 'spinostics'.
    Scientific Reports 03/2013; 3:1525. DOI:10.1038/srep01525 · 5.58 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Traditional cancer treatment strategies include systemic chemotherapy, external beam radiation, and surgical excision. Chemotherapy is nonspecific, and targets all rapidly dividing cells. External beam radiation and surgery only target known cancer sites. However, targeted therapeutics, such as antibodies, will bind to all cancer cells that express the targeted antigen, including small metastases that are invisible by current imaging technology. In the past decade, nine antibodies have been approved for the treatment of cancer and are demonstrating moderate success in the clinic. Some of these antibodies have intrinsic toxic effects and block the interaction of growth factors or induce cell death. Other antibodies are conjugated to drugs, toxins, or radioactive isotopes. Unfortunately, antibodies exhibit slow clearance from the body and exposure of healthy tissues to toxins or radiation can result in undesirable side effects that limit the doses that can be safety administered to the patient. We have used rational engineering design and mathematical modeling to develop a novel pretargeted radioimmunotherapy (PRIT) approach for the treatment of cancer. In PRIT, a bifunctional antibody is administered and allowed to bind to a cancer antigen. After sufficient tumor uptake of the antibody, a small molecule carrying a radionuclide is administered and captured by the pretargeted antibody while unbound molecules clear rapidly from the body. PRIT combines the high binding specificity of antibodies with the rapid clearance properties of small molecules. We have identified a small molecule metal chelate, DOTA, which exhibits rapid whole-body clearance and that has demonstrated safety in humans.
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper presents an efficient approach to short term power system resource scheduling based on the augmented Lagrangian relaxation method. The problem is divided into two stages, the commitment stage and the constrained economic dispatch stage. The proposed mathematical model incorporates optimal power flow (OPF) constraints in the unit commitment stage. By OPF constrains, the authors refer to the relevant active power constraints that are incorporated in the constrained economic dispatch stage (i.e. transmission capacity constraints, fuel and various regulated emission requirements). The inclusion of OPF constraints in the commitment stage will improve the feasibility of the constrained economic dispatch solution. Other unit commitment constraints such as spinning and operating reserve requirements, power balance as well as other relevant local constraints (i.e. unit ramping rates, upper and lower generation limits, minimum up and down times) are taken into account in the proposed model. As a larger number of constraints are dealt with, a more rigorous method is introduced for updating Lagrange multipliers to improve the solution convergence. A software package which addresses energy management systems requirements is developed and tested
    Power Industry Computer Application Conference, 1995. Conference Proceedings., 1995 IEEE; 06/1995
Show more